Adam R. Craig
Net Worth

Last updated:

What is Adam R. Craig net worth?

The estimated net worth of Dr. Adam R. Craig is at least $8,632,778 as of 24 Jan 2023. He has earned $4,512,778 from insider trading and has received compensation worth at least $4,120,000 in CTI BioPharma Corp..

What is the salary of Adam R. Craig?

Dr. Adam R. Craig salary is $1,030,000 per year as Pres, Chief Executive Officer, Interim Chief Medical Officer & Director in CTI BioPharma Corp..

How old is Adam R. Craig?

Dr. Adam R. Craig is 59 years old, born in 1966.

What stocks does Adam R. Craig currently own?

As insider, Dr. Adam R. Craig owns shares in one company:

Company Title Shares Price per share Total value
CTI BioPharma Corp. (CTIC) Pres, Chief Executive Officer, Interim Chief Medical Officer & Director 29,440 $0 $0

What does CTI BioPharma Corp. do?

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

CTIC logo
CTIC
CTI BioPharma Corp.

Adam R. Craig insider trading

CTI BioPharma Corp.

Dr. Adam R. Craig has made 21 insider trades between 2021-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 242,300 units of CTIC stock on 12 Sep 2022. As of 24 Jan 2023 he still owns at least 29,440 units of CTIC stock.

Transaction Date Security Shares Price per share Total value Source
Option
Non-Qualified Stock Option (right to buy) 2,117 $0.84 $1,780
Option
common stock 83,200 $0.84 $69,971
Option
Non-Qualified Stock Option (right to buy) 83,200 $0.84 $69,971
Sale
common stock 2,117 $6.01 $12,723
Option
common stock 2,117 $0.84 $1,780
Option
Non-Qualified Stock Option (right to buy) 84,683 $0.84 $71,218
Sale
common stock 84,683 $6.01 $509,199
Option
common stock 84,683 $0.84 $71,218
Sale
common stock 4,400 $6.01 $26,444
Option
common stock 700 $0.84 $589
Option
Non-Qualified Stock Option (right to buy) 4,400 $0.84 $3,700
Option
common stock 12,000 $0.84 $10,092
Option
Non-Qualified Stock Option (right to buy) 12,000 $0.84 $10,092
Option
Non-Qualified Stock Option (right to buy) 700 $0.84 $589
Option
common stock 4,400 $0.84 $3,700
Option
Non-Qualified Stock Option (right to buy) 13,800 $0.84 $11,606
Option
common stock 13,800 $0.84 $11,606
Sale
common stock 13,800 $6 $82,800
Option
common stock 188,304 $0.84 $158,364
Option
Non-Qualified Stock Option (right to buy) 188,304 $0.84 $158,364
Sale
common stock 2,700 $6.04 $16,308
Sale
common stock 5,800 $6.03 $34,974
Sale
common stock 16,396 $6.02 $98,704
Sale
common stock 100 $6.02 $602
Sale
common stock 26,700 $6.01 $160,467
Sale
common stock 200 $6.01 $1,201
Sale
common stock 136,408 $6 $818,448
Sale
common stock 46,100 $6 $276,600
Option
Non-Qualified Stock Option (right to buy) 53,996 $0.84 $45,411
Option
common stock 53,996 $0.84 $45,411
Sale
common stock 7,596 $6.01 $45,652
Sale
common stock 300 $6.02 $1,805
Option
Non-Qualified Stock Option (right to buy) 242,300 $0.84 $203,774
Option
Common Stock 242,300 $0.84 $203,774
Sale
Common Stock 242,300 $6.43 $1,557,989
Purchase
common stock 5,000 $5.5 $27,500
Option
Non-Qualified Stock Option (right to buy) 18,223 $0.84 $15,326
Option
Non-Qualified Stock Option (right to buy) 27,000 $0.84 $22,707
Sale
common stock 18,223 $6.11 $111,343
Option
common stock 18,223 $0.84 $15,326
Option
Non-Qualified Stock Option (right to buy) 27,000 $0.84 $22,707
Option
common stock 27,000 $0.84 $22,707
Sale
common stock 27,000 $6 $162,000
Option
common stock 27,000 $0.84 $22,707
Sale
common stock 27,000 $6 $162,000
Sale
common stock 18,223 $6.01 $109,520
Option
Non-Qualified Stock Option (right to buy) 36,446 $0.84 $30,651
Option
Non-Qualified Stock Option (right to buy) 54,000 $0.84 $45,414
Option
common stock 27,000 $0.84 $22,707
Option
common stock 18,223 $0.84 $15,326
Option
Non-Qualified Stock Option (right to buy) 54,000 $0.84 $45,414
Option
common stock 27,000 $0.84 $22,707
Option
common stock 18,223 $0.84 $15,326
Option
common stock 27,000 $0.84 $22,707
Sale
common stock 27,000 $6 $162,000
Option
common stock 27,000 $0.84 $22,707
Sale
common stock 27,000 $6 $162,000
Purchase
common stock 1,322 $1.53 $2,016
Purchase
common stock 2,178 $1.53 $3,321

CTI BioPharma Corp. key executives

CTI BioPharma Corp. executives and other stock owners filed with the SEC: